Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 1, 2015Medical Science MonitorOpen Access

Comparative Metabolomic Profiling of Hepatocellular Carcinoma Cells Treated with Sorafenib Monotherapy vs. Sorafenib-Everolimus Combination Therapy

View Full Paper
Ask AI
Bookmark
Share

Authors

JZJixiang ZhangTianjin University of Science and Technology

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Jixiang Zhang (2015) studied this question.

synapsesocial.com/papers/6ab5ded0d366ac9ba23cf685https://doi.org/10.12659/msm.894669
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Utilization of Quantitative In Vivo Pharmacology Approaches to Assess Combination Effects of Everolimus and Irinotecan in Mouse Xenograft Models of Colorectal Cancer2013 · 33 citations
  2. 2MetaboAnalyst 2.0--a comprehensive server for metabolomic data analysis2012 · 1,164 citations
  3. 3Evaluation of the Orthogonal Projection on Latent Structure Model Limitations Caused by Chemical Shift Variability and Improved Visualization of Biomarker Changes in 1 H NMR Spectroscopic Metabonomic Studies2004 · 558 citations
  4. 4Quantitative two‐dimensional HRMAS 1H‐NMR spectroscopy‐based metabolite profiling of human cancer cell lines and response to chemotherapy2010 · 52 citations
  5. 5First interim analysis of the GIDEON (Global Investigation of therapeutic DEcisions in hepatocellular carcinoma and Of its treatment with sorafeNib) non-interventional study2012 · 111 citations